Exodus Point Capital Management, LP Edgewise Therapeutics, Inc. Transaction History
Exodus Point Capital Management, LP
- $11.4 Billion
- Q2 2025
A detailed history of Exodus Point Capital Management, LP transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 45,255 shares of EWTX stock, worth $694,664. This represents 0.01% of its overall portfolio holdings.
Number of Shares
45,255Holding current value
$694,664% of portfolio
0.01%Shares
7 transactions
Others Institutions Holding EWTX
# of Institutions
191Shares Held
118MCall Options Held
54.3KPut Options Held
70.1K-
Orbimed Advisors LLC San Diego, CA15.5MShares$238 Million7.26% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.9MShares$152 Million2.84% of portfolio
-
Baker Bros. Advisors LP New York, NY7.31MShares$112 Million0.97% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY6.14MShares$94.3 Million3.76% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$92.3 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $970M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...